Lilly Chai
Target (United States)(US)Sanofi (United States)(US)
Publications by Year
Research Areas
Quinazolinone synthesis and applications, Synthesis and biological activity, Cellular transport and secretion, Lysosomal Storage Disorders Research, Parkinson's Disease Mechanisms and Treatments
Most-Cited Works
- → Discovery of Aminoquinazolines as Potent, Orally Bioavailable Inhibitors of Lck: Synthesis, SAR, and in Vivo Anti-Inflammatory Activity(2006)67 cited
- → Knockdown of human deubiquitinase PSMD14 induces cell cycle arrest and senescence(2009)64 cited
- → Structure-Based Design of Novel 2-Amino-6-phenyl-pyrimido[5′,4′:5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as Potent and Orally Active Inhibitors of Lymphocyte Specific Kinase (Lck): Synthesis, SAR, and In Vivo Anti-Inflammatory Activity(2008)63 cited
- → Novel 2-Aminopyrimidine Carbamates as Potent and Orally Active Inhibitors of Lck: Synthesis, SAR, and in Vivo Antiinflammatory Activity(2006)61 cited
- → Structure-Guided Design of Aminopyrimidine Amides as Potent, Selective Inhibitors of Lymphocyte Specific Kinase: Synthesis, Structure–Activity Relationships, and Inhibition of in Vivo T Cell Activation(2008)22 cited
- → Discovery of 2,4-bis-arylamino-1,3-pyrimidines as insulin-like growth factor-1 receptor (IGF-1R) inhibitors(2011)17 cited
- → Network Analysis and Human Single Cell Brain Transcriptomics Reveal Novel Aspects of Alpha-Synuclein (SNCA) Biology(2020)5 cited
- → AAV gene therapy for GBA1-related diseases(2025)
- → AAV gene therapy for GBA-PD and Gaucher Disease(2025)